Articles published by Astria Therapeutics, Inc.
![](https://mms.businesswire.com/media/20240830515969/en/2226298/22/Astria_logo.jpg)
Astria Therapeutics to Present at Upcoming Bradykinin Symposium
August 30, 2024
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240829008062/en/2226289/22/Astria_logo.jpg)
Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare Conference
August 29, 2024
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240812507497/en/2213475/22/Astria_logo.jpg)
Astria Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
August 12, 2024
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240812920696/en/2213515/22/Astria_logo.jpg)
![](https://mms.businesswire.com/media/20240807566138/en/2208500/22/Astria_logo.jpg)
Astria Therapeutics to Participate in Upcoming 2024 Wedbush PacGrow Healthcare Conference
August 07, 2024
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240802889453/en/2204954/22/Astria_logo.jpg)
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240604642793/en/2150337/22/Astria_logo.jpg)
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240530854297/en/2144878/22/Astria_logo.jpg)
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240524680301/en/2139872/22/Astria_logo.jpg)
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240523463861/en/2139117/22/Astria_logo.jpg)
![](https://mms.businesswire.com/media/20240509444014/en/2126357/22/Astria_logo.jpg)
![](https://mms.businesswire.com/media/20240508669745/en/2121862/22/Astria_logo.jpg)
![](https://mms.businesswire.com/media/20240502558704/en/2118166/22/Astria_logo.jpg)
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240409245984/en/2092686/22/Astria_logo.jpg)
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240403027074/en/2087138/22/Astria_logo.jpg)
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240325940590/en/2078441/5/PR_Graph.jpg)
![](https://mms.businesswire.com/media/20240305596953/en/2055382/22/Astria_logo.jpg)
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240304317219/en/2051979/22/Astria_logo.jpg)
![](https://mms.businesswire.com/media/20240220427055/en/2037230/22/Astria_logo.jpg)
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
February 20, 2024
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240206223566/en/2019738/22/Astria_logo.jpg)
Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240205831113/en/2019730/22/Astria_logo.jpg)
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2024
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20240130417221/en/2014053/22/MicrosoftTeams-image.jpg)
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20231204645787/en/1959386/22/Astria_logo.jpg)
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2023
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20231127875051/en/1952569/22/MicrosoftTeams-image.jpg)
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20231121631663/en/1949707/22/MicrosoftTeams-image.jpg)
Astria Therapeutics to Present at Upcoming 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20231113805218/en/1942427/22/Astria_logo.jpg)
Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update
November 13, 2023
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20231110656373/en/1941619/22/Astria_logo.jpg)
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20231109732128/en/1939840/22/Astria_logo.jpg)
Via Business Wire
Tickers
ATXS
![](https://mms.businesswire.com/media/20231103952162/en/1934106/22/Astria_logo.jpg)
![](https://mms.businesswire.com/media/20231102010548/en/1933421/22/MicrosoftTeams-image.jpg)
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 02, 2023
Via Business Wire
Tickers
ATXS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.